Clinical Trial Update: Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment

View source ↗

Summary

This ClinicalTrials.gov update reports on an observational study evaluating lenalidomide in patients with mantle cell lymphoma who failed ibrutinib treatment. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Lymphoma, Mantle-Cell | Status: COMPLETED